AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Oluwafemi Masha

Appears inactive Last observed office action: October 2014 (137 months ago).

Examiner Oluwafemi Masha appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 76.7%, they average 1.52 office actions per granted patent, and their rejection profile leans toward §112, with occasional §101 rejections and elevated §112 usage.

Difficulty vs AU Very Easy
Difficulty vs Group Very Easy
Difficulty vs TC Very Easy
Difficulty vs USPTO Very Easy
Average OA / Grant 1.52
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2010-2014)
Tech Center
1600 - Biotechnology and Organic
Group
1620 - Biomedicinal Chemistry

Metrics

Applications Evaluated
60
Granted Applications
46
Non-Granted Applications
14
Avg OA / Grant
1.52
Last OA Observed
October 2014 (137 months ago)
Art Units Seen
1624
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 76.7% 1.52
Art Unit 32 55.8% 1.59
Group 248 48.3% 1.76
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2010 2012 2013 2014
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2010; examiner may not yet have been active in the available dataset.
2010 1 1 100.0%
No observed data for 2011.
2012 2 1 50.0%
2013 33 23 69.7%
2014 24 21 87.5%
No observed data after 2014; examiner may have gone inactive or moved out of examining work.

46 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 60 5.0% 16.7% 16.7% 36.7%
2 21 0.0% 19.0% 14.3% 28.6%
3 5 0.0% 20.0% 40.0% 40.0%
4 1 0.0% 0.0% 0.0% 100.0%

§ 101 Yearly Trend

50.0%
2010
0.0%
2011
0.0%
2012
2.1%
2013
3.7%
2014

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.